Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
86
datasets available to search
ShareScore release 0.9.0
Dataset results
86 results for “Dementia with Lewy Body”
Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue
Open the record for dataset details and reuse information.
Data from: Cough reflex sensitivity and urge-to-cough deterioration in dementia with Lewy bodies
Cough, an important respiratory symptom, predominantly involves the brainstem, and the urge-to-cough is modulated by the cerebral cortex. Lewy body disease is associated with decreased cough reflex sensitivity and central respiratory chemosensitivity. Additionally, the insula, associated with the urge-to-cough, shows decreased activation and atrophy in dementia with Lewy bodies (DLB). We investigated the relationships between cognition and cough reflex and the urge-to-cough and compared the differences in responses of patients with DLB and other dementia subtypes. We conducted a cross-sectional study within a geriatric ward of a university hospital involving elderly patients diagnosed with Alzheimer's disease (AD), DLB, or non-dementia (controls). The cough reflex sensitivities were estimated based on the lowest concentrations of inhaled citric acid that could induce ≥2 coughs (C2) or ≥5 coughs (C5). Subjects were asked to rate the urge-to-cough based on the threshold concentrations (Cu) using the modified Borg scale. C2, C5, and Cu were negatively correlated with cognitive function in female participants but not in males (P<0.01). The cough reflex sensitivity expressed as C2 and C5 were significantly higher in the DLB group than in the AD and control groups (P<0.01 adjusted for gender). The urge-to-cough threshold expressed as Cu was also significantly higher, while the urge-to-cough log–log slope was less responsive with the increasing cough-evoking stimuli in the DLB group than that in the other groups. The cough reflex sensitivity and perceived urge-to-cough deteriorated in the DLB group than in the other groups. This result might be valuable in treating patients with DLB.
Differential methylation analysis in neuropathological confirmed dementia with Lewy bodies
<p>Authors: Paolo Reho, Sara Saez-Atienzar, Sultana Solaiman, Zalak Shah, Ruth Chia, Karri Kaivola, Bryan J. Traynor, Bension S. Tilley, Steve M. Gentleman, Angela K. Hodges, Dag Aarsland, Edwin S. Monuki, Kathy L. Newell, Randy Woltjer, Marilyn S. Albert, Ted M. Dawson, Liana S. Rosenthal, Juan C. Troncoso, Olga Pletnikova, Geidy E. Serrano, Thomas G. Beach, Hariharan P. Easwaran, Sonja W. Scholz</p> <p>Epigenome-wide association study investigating epigenetic modulations in a cohort of neuropathologically confirmed dementia with Lewy bodies cases and neurologically healthy controls.</p>
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
ClinicalTrials.gov study NCT03305809. IPD Sharing: YES. Countries: 3. Publications: 2.
Impact of Bosutinib on Safety, Tolerability, Biomarkers and Clinical Outcomes in Dementia With Lewy Bodies
ClinicalTrials.gov study NCT03888222. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase
ClinicalTrials.gov study NCT01278407. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
ClinicalTrials.gov study NCT04001517. IPD Sharing: NO. Countries: 2. Publications: 2.
Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
ClinicalTrials.gov study NCT05225415. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
ClinicalTrials.gov study NCT04002674. IPD Sharing: NO. Countries: 1. Publications: 1.
Learning to PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
ClinicalTrials.gov study NCT04649164. IPD Sharing: NO. Countries: 1. Publications: 1.
Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies
ClinicalTrials.gov study NCT03467152. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Data from: Cough reflex sensitivity and urge-to-cough deterioration in dementia with Lewy bodies
Open the record for dataset details and reuse information.
Transcranial Alternating Current Stimulation in Lewy Body Dementia
ClinicalTrials.gov study NCT07375771. IPD Sharing: Not stated. Countries: 1. Publications: 25.
Deep Brain Stimulation for Patients With Dementia With Lewy Bodies
ClinicalTrials.gov study NCT02263937. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Terazosin for Dementia With Lewy Bodies
ClinicalTrials.gov study NCT04760860. IPD Sharing: YES. Countries: 1. Publications: 2.
Ambroxol as a Novel Disease Modifying Treatment for Lewy Body Dementia
ClinicalTrials.gov study NCT04405596. IPD Sharing: Not stated. Countries: 1. Publications: 20.
Memantine Versus Placebo in Parkinson's Disease Dementia or Dementia With Lewy Bodies
ClinicalTrials.gov study NCT00855686. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Novel Machine Learning Algorithm to Predict the Lewy Body Dementias
ClinicalTrials.gov study NCT04448340. IPD Sharing: NO. Countries: 1. Publications: 1.
Imaging of Vesicular Acetylcholine and Dopamine Transporters in Dementia With Lewy Bodies
ClinicalTrials.gov study NCT00917709. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Self and Autobiographical Memory in Dementia With Lewy Bodies and Alzheimer Disease: a Behavioral and Multimodal Neuroimaging Study
ClinicalTrials.gov study NCT04616287. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.